Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-029406
Filing Date
2024-12-16
Accepted
2024-12-16 09:25:06
Documents
1
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 form4-12162024_091201.html 4  
1 form4-12162024_091201.xml 4 8423
  Complete submission text file 0001415889-24-029406.txt   10104
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CAPRICOR THERAPEUTICS, INC. 8840 WILSHIRE BLVD., 2ND FLOOR BEVERLY HILLS CA 90211
Business Address
Krasney Karen (Reporting) CIK: 0001593086 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 241550299